A phase III multicentre double blind randomised trial of celecoxib versus placebo following chemotherapy in primary breast cancer patients.
Phase of Trial: Phase III
Latest Information Update: 22 May 2018
At a glance
- Drugs Celecoxib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms REACT
- 09 Dec 2017 Results assessing safety and efficacy presented at the 40th Annual San Antonio Breast Cancer Symposium
- 02 Mar 2016 Status changed from active, no longer recruiting to completed as per ISRCTN: Current Controlled Trials record.
- 07 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History